Colonoscopy and Sigmoidoscopy are Equally Effective for the Diagnosis of Colonic Acute Graft-versus-Host Disease in Patients with Diarrhea after Allogeneic Stem Cell Transplantation: A Prospective Controlled Trial  by Johansson, Jan-Erik et al.
Biol Blood Marrow Transplant 21 (2015) 2086e2090Biology of Blood and
Marrow Transplantation
journal homepage: www.bbmt.orgClinical Research: AdultColonoscopy and Sigmoidoscopy are Equally Effective
for the Diagnosis of Colonic Acute Graft-versus-Host
Disease in Patients with Diarrhea after Allogeneic Stem
Cell Transplantation: A Prospective Controlled TrialJan-Erik Johansson 1,*, Ola Nilsson 2, Per-Ove Stotzer 3
1Department of Hematology & Coagulation, Sahlgrenska University Hospital, Göteborg, Sweden
2Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
3Department of Gastroenterology, Sahlgrenska University Hospital, Göteborg, SwedenArticle history:
Received 23 May 2015
Accepted 7 July 2015
Key Words:
Colonoscopy
Sigmoidoscopy
Graft-versus-host disease
IntestinalFinancial Disclosure: See Acknowl
* Correspondence and reprint r
Associate Professor, Department of
University Hospital, SE 413 45, Göt
E-mail address: jan-erik.j.johan
http://dx.doi.org/10.1016/j.bbmt.20
1083-8791/ 2015 American Sociea b s t r a c t
Colonic acute graft-versus-host disease (aGVHD) affects approximately 10% of patients who have undergone
allogeneic stem cell transplantation (allo-SCT). Diarrhea is a major clinical sign but also a common post-
transplantation symptom in these patients. Comprehensive histopathologic examination of the colon is
therefore regarded as crucial to establish a diagnosis, but the colonic segment that should be targeted for a
diagnostic biopsy remains a topic of debate. The primary objective of this study was to compare prospectively
colonoscopy with sigmoidoscopy regarding their capabilities to provide a histopathologically proven diag-
nosis of colonic aGVHD. Thirty-seven allo-SCT patients with diarrhea all underwent a colonoscopy. All bi-
opsies collected from the descending colon were regarded as also attainable by sigmoidoscopy, whereas
biopsies collected in regions further up the colon (from the transverse and ascending colon) were regarded as
acquirable exclusively by colonoscopy. Biopsies attainable by colonoscopy and sigmoidoscopy were positive
for GVHD in 25 (68%) and 24 (65%) patients, respectively (95% conﬁdence interval for difference of pro-
portions, .185 to .245; P ¼ .978; z ¼ .0271 by the z-test). Sigmoidoscopy is as effective as colonoscopy in
establishing a diagnosis of colonic aGVHD in patients who have diarrhea after allo-SCT.
 2015 American Society for Blood and Marrow Transplantation.INTRODUCTION
Gastrointestinal (GI) acute graft-versus-host disease
(aGVHD) affects approximately 20% to 50% of patients who
undergo allogeneic stem cell transplantation (allo-SCT) when
the diagnosis is based primarily on clinical symptoms and
ﬁndings [1,2]. The prognosis for certain high-risk patients can
be very poor [3]. In patients with aGVHD of the lower GI tract,
diarrhea is the main symptom, frequently accompanied by
abdominal pain and/or bleeding.Measurement of the volume
of diarrhea is essential for evaluating the grade of disease,
which is inversely correlated with survival [4,5].
Because diarrhea is a common post-transplantation
symptom, it is essential to distinguish patients with colonicedgments on page 2089.
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ty for Blood and Marrow Transplantation.aGVHD from patients who have other treatable conditions,
such as cytomegalovirus (CMV) colitis, the course of which
may be exacerbated by treatments that entail increased
immunosuppression. Therefore, histopathology has become
a critical tool in establishing a diagnosis of intestinal aGVHD.
Although not diagnostic of GVHD, the cardinal histopatho-
logic criterion is the presence of epithelial single-cell ne-
crosis (apoptosis) that may or may not be accompanied by
increased inﬂammation and reactive accompanying epithe-
lial changes or loss [6-9]. In a previous report, the incidence
of colonic aGVHD was found to be approximately 10%, based
on histopathologic ﬁndings [10]. However, the colonic
segment that should be targeted for a diagnostic biopsy re-
mains a topic of debate [11-13], and prospective trials to
address this issue are lacking.
The only way to obtain biopsies from the entire colon is to
perform a colonoscopy. However, preparation for this pro-
cedure is challenging for both patients and clinical staff. The
alternative to colonoscopy is sigmoidoscopy, for which the
Table 1
Patient Characteristics
Positive
Histopathology
(n ¼ 25)
Negative
Histopathology
(n ¼ 12)
P
Median age, yr (range) 53 (32-65) 60 (20-68) .42
Gender
Male 14 (56) 7 (58) .81
Female 11 (44) 5 (42)
Diagnosis
Acute leukemia/MDS 11 (44) 5 (42) d
CML 3 (12) 3 (25)
CLL/lymphoma 9 (36) 2 (17)
MPD 1 (4) 2 (17)
Hemophagocytosis 1 (4) 0
Conditioning
MAC 8 (32) 5 (42) .82
RIC 17 (68) 7 (58)
Donor
Related 10 (40) 3 (25) .60
Matched unrelated 15 (60) 9 (75)
Stem cell source
Peripheral blood 24 (96) 11 (92) .78
Bone marrow 1 (4) 1 (8)
Median CD34 content, 106/kg
(range)
4.0 (3.0-6.5) 4.4 (1.3-6.9) .91
Median serum albumin
concentration, g/L (range)
36 (14-48) 42 (31-46) .25
Number of biopsies per patient
(range)
11 (6-24) 10 (6-23) .77
Interval between transplant and
colonoscopy, days (range)
96 (19-715) 63 (19-852) .45
MDS indicates myelodysplastic syndrome; CML, chronic myelogenous
leukemia; CLL, chronic lymphocytic leukemia; MPD, myeloproliferative
disorder; MAC, myeloablative conditioning; RIC, reduced-intensity condi-
tioning;d, not siigniﬁcant
Values are total number of cases with percents in parentheses, unless
otherwise noted.
Table 2
Endoscopic Grading of GI GVHD
Grade Finding
0 Normal
1 Loss of vascular markings and/or presence of focal mild
erythema
2 Moderate edema and/or erythema
3 Edema, erythema, erosions, and/or bleeding
4 Ulceration, exudates, and bleeding
The endoscopic image was graded as positive (grades 1-4) or negative
(grade 0) for GI GVHD according to a validated scale adapted from Cruz-
Correa et al. [9].
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onerous and time-consuming than colonoscopy. However,
because only a portion of the target organ is examined, there
is a potential risk of missing the characteristic histopatho-
logic ﬁndings and thereby underdiagnosing colonic GVHD
in case this is not regarded to be a pan-colonic disease. In the
controlled clinical trial described here, we prospectively
compared biopsies attainable by colonoscopy with biopsies
attainable by sigmoidoscopy to see whether we could obtain
a histopathologically proven colonic GVHD diagnosis in adult
patients with diarrhea after allo-SCT.
METHODS
Patients
Between May 2004 and January 2013, 248 adult patients (18 years of
age) underwent allo-SCT at the department of Hematology and Coagulation
at Sahlgrenska University Hospital, Göteborg, Sweden. Thirty-seven patients
were included in the study. The inclusion criterion was signiﬁcant diarrhea
with or without abdominal pain and/or bleeding, nausea, or vomiting any
time after allo-SCT.
During the study interval 18 additional patients underwent sigmoid-
oscopy, of whom 8 fulﬁlled the inclusion criterion but were not included
because of missed informed consent (n ¼ 3) or at the discretion of the
responsible clinician (patients could not manage the preparation procedure
for a colonoscopy; n ¼ 5). Five of these 8 patients (63%) exhibited positive
histopathology for GVHD. The remaining 10 patients who underwent
sigmoidoscopy did not fulﬁll the inclusion criterion but instead had more
unspeciﬁc GI symptoms like abdominal pain and/or rectal bleeding. A GVHD
diagnosis could not be established in any of these 10 cases.
Patients without diarrhea who instead only had symptoms from the
upper GI tract (anorexia, nausea, vomiting, upper abdominal pain, and
early satiety) routinely underwent a gastroduodenoscopy and were not
included in the study. Seven of the 37 included patients underwent a
gastroduodenoscopy during the study but only in 1 case in connection
with the colonoscopy. In this single case histopathologic evidence
of gastric/duodenal GVHD could be established but not in the remaining 6
cases.
Patient characteristics are presented in Table 1. All patients gave
informed consent before inclusion.
Clinical Grading
Findings consistent with aGVHD of the skin and liver were recorded
prospectively, and overall aGVHD was staged and graded according to
established criteria [4,5]. Intestinal stage and grade were based on the
maximal daily volume of diarrhea (rounded to the nearest 100 mL) and
the presence of any bleeding. Stool samples were examined for bacteria
(including culturing for Clostridium difﬁcile), fungi, and viruses (PCR for
calicivirus, adenovirus, astrovirus, and rotavirus), although colonoscopy was
not delayed to wait for these results.
Endoscopic Preparation and Grading
All 37 patients underwent a colonoscopy (Olympus CF160L or Olympus
CF 180L; Olympus, Tokyo, Japan), with procedures performed by 7 different
experienced endoscopists. The preparation for the procedure included oral
administration of 2 to 4 L polyethylene glycol (Laxabon; BioPhausia, Stock-
holm, Sweden), except for 2 patients who instead received orally (2  45
mL) disodium phosphate dodecahydrate/sodium dihydrogen phosphate
dehydrate (Phosphoral; CCS Healthcare, Borlange, Sweden). One patient was
excluded from the study because the examination was terminated before
the entire colon could be examined. It was at the discretion of the respon-
sible clinician to decide if treatment with cortisone could be postponed until
after the colonoscopy.
As a minimum, 2 biopsies were collected according to a speciﬁc study
algorithm from each of the following sites: ascending colon, transverse
colon, and descending colon (for a minimum of 6 biopsies per patient). The
biopsies were taken preferentially from areas that showed macroscopic
changes or otherwise from areas with normal endoscopic ﬁndings. Based
on the endoscopic ﬁndings, macroscopic grading was performed using a
4-point scale adapted from Cruz-Correa et al. [9] (Table 2).
All biopsies collected from the descending colon (up to the left colic
ﬂexure) were regarded as attainable by sigmoidoscopy, whereas biopsies
collected in regions further up the colon (from the transverse and ascending
colon) were regarded as attainable exclusively by colonoscopy. Thus, all
37 patients were regarded to have undergone both sigmoidoscopy and
colonoscopy on the same occasion, and, accordingly, each patient served as
their own control (for a total of 37 matched pairs).Histopathologic Preparation and Grading
All mucosal biopsy specimens were ﬁxed in 4.5% buffered formalin and
stained with hematoxylin and eosin as well as being routinely stained for
CMV. The same experienced pathologist conducted a nonblinded evaluation
of sections from all 421 biopsy samples. Based on this evaluation, histologic
grading was performed using a 4-point validated scale adapted from Cruz-
Correa et al. [9] (Table 3). Assignment of a histologic grade of 1 or higher
(>2 apoptotic cell bodies per cryptic proﬁle) was considered to be suggestive
of aGVHD. The detection of 2 apoptotic bodies per cryptic proﬁle was
regarded as a nonspeciﬁc ﬁnding and as not being consistent with a diag-
nosis of aGVHD in this study.
Statistical Analyses
The primary statistical outcome in the study was colonic aGVHD based
on a positive biopsy (grades 1 to 4). The required number of patients was
based on a study of dependent variables with paired observations and a 2-
sided alternative hypothesis with a signiﬁcance level of 5%. The incidence of
colonic GVHD was estimated to be 10% in the population studied. To obtain
80% power, it was calculated that 37 paired observations (74 observations in
total) were required. Continuous and categorical variables were analyzed
using the Mann-Whitney U-test and Fisher’s exact test, respectively. When
comparing percentages across groups, a z-test was used.
Table 3
Histologic Grading of GI GVHD
Grade Finding
0 Normal
1 Increased crypt apoptosis*
2 Apoptosis with crypt abscess
3 Individual crypt necrosis
4 Total denudation of areas of mucosa
The same experienced pathologist conducted an evaluation of hematoxylin
and eosin-stained sections from all 421 biopsy samples; based on this
evaluation, histologic grading was performed using a system for GI GVHD
grading adapted from Cruz-Correa et al. [9].
* Three or more apoptotic cell bodies per cryptic proﬁle (the detection
of 2 apoptotic bodies was regarded as a nonspeciﬁc ﬁnding and as not
being consistent with aGVHD in these patients).
Table 4
Clinical Outcomes for the 37 Patients with Acute Colonic GVHD and Diarrhea
Positive
Histopathology
(n ¼ 25)
Negative
Histopathology
(n ¼ 12)
P
Endoscopic grade
0 6 9 d
1 6 2
2 4 1
3 8 0
4 1 0
Histopathologic grade
0 0 12 d
1 10 0
2 7 0
3 6 0
4 2 0
Overall aGVHD grade
0 0 8 d
1 0 4
2 15 0
3 9 0
4 1 0
aGVHD organ involvement
Colon þ liver 1 0 d
Colon þ skin 10 0
Colon þ skin þ liver 6 0
Colon only 8 0
Skin only 0 4
Noncolonic aGVHD (skin/
liver) (%)
17 (68) 4 (33) .10
Median diarrhea volume at
time of biopsy, mL (range)
900 (600-2600) 600 (500-1300) .025
Cause of diarrhea
GVHD 23 0 d
GVHD þ CMV 2 0
CMV alone 0 0
Side effect of medication 0 6
Viral gastroenteritis 0 1
Clostridium difﬁcile infection 0 3
Thyrotoxicosis 0 1
Unknown 0 1
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The median time from transplant to colonoscopy was
80 days (range, 19 to 852). A diagnosis of colonic aGVHD
based on histopathologic ﬁndings (grades 1 to 4) was
established in 25 of 37 patients (68%), giving an incidence of
colonic aGVHD of 10% (25/248 patients). Two patients were
diagnosed with CMV colitis in addition to colonic aGVHD.
The diagnoses among the 12 patients who had diarrhea but
were negative for histopathology (grade 0) were clostridium
enteritis (n ¼ 3), side effects of medication (n ¼ 6), viral
gastroenteritis (n ¼ 1), thyrotoxicosis (n ¼ 1), and unknown
(n ¼ 1).
Eight and 4 patients had isolated colonic and skin
involvement of aGVHD, respectively, whereas 17 patients
had combined colonic and skin and/or liver involvement.
Eight patients did not have any aGVHD at all (grade 0). The 11
patients whowere diagnosed with colonic aGVHDmore than
100 days after transplantation had all been treated with
tapered immunosuppression and/or donor lymphocyte
infusion due to threatened or manifested relapse. The me-
dian time from donor lymphocyte infusion (n¼ 7) to onset of
aGVHD in these patients was 21 days (range, 15 to 57).
No signiﬁcant complications related to colonoscopy were
recorded before, during, or after the procedure. The clinical
outcomes for the included patients are summarized in
Table 4.
In total, 421 biopsies were collected (on average, 11
biopsies per patient), and there was no difference in biopsy
number between patients with or without colonic aGVHD.
All biopsies from all 3 different colonic areas were positive
for GVHD (grades 1 to 4) in 25 patients. In 1 patient, all
biopsies from the descending colon were negative but all
biopsies from the 2 other locations (ascending and trans-
verse colon) were positive. Thus, 24 of 37 (65%) colonic
aGVHD diagnoses were attainable within the sampling range
of sigmoidoscopy, whereas 25 of 37 (68%) aGVHD diagnoses
were achievable within the sampling range of colonoscopy.
There was no signiﬁcant difference in the percentages of
positive biopsies attainable by sigmoidoscopy and colonos-
copy (95% conﬁdence interval [CI] for difference, .185 to
.245; P ¼ .978; z ¼ .0271 by the z-test). Assuming colonos-
copy to be the gold standard, the sensitivity, speciﬁcity, and
positive and negative predictive values for sigmoidoscopy
were 96% (95% CI, 79.7% to 99.9%), 100% (95% CI, 73.5% to
100%), 100% (95% CI, 85.8% to 100%), and 92.3% (95% CI, 64.0%
to 99.8%), respectively.
Overall, 19 of 25 patients (76%) who had positive histo-
pathologic ﬁndings also had positive endoscopic ﬁndings,
whereas only 3 of 12 patients (25%) who lacked histopath-
ologic ﬁndings showed corresponding endoscopic ﬁndings.The positive and negative predictive values for endoscopic
ﬁndings were 86% (95% CI, 65.1% to 96.9%) and 60% (95% CI,
32.3% to 83.6%), respectively. Furthermore, patients who
exhibited positive histopathology for GVHD in their biopsies
had signiﬁcantly larger volumes of diarrhea than patients
who showed negative biopsies. There was a nonsigniﬁcant
difference in the percentages of patients with noncolonic
aGVHD (skin and/or liver) between patients with or without
positive histopathology (Table 4).
DISCUSSION
The main ﬁnding of this prospective study is that biopsies
attainable by sigmoidoscopy and colonoscopy are equally
effective in establishing a histopathologically proven diag-
nosis of colonic aGVHD in patients who have diarrhea after
allo-SCT. Although this ﬁnding is not entirely novel, to the
best of our knowledge this is the ﬁrst prospective, controlled
study to show this. The strength of the study is its design (all
patients underwent a colonoscopy and accordingly simulta-
neously also a sigmoidoscopy), whereby each included pa-
tient served as his or her own control, giving 2 perfectly
matched study groups. This minimizes confounding factors
that might affect both the indication for and the outcome of
the endoscopic procedures. The incidence of colonic aGVHD
(mid to lower GI GVHD) detected in the present study (10%)
is in linewith that reported in an earlier published study [10].
The present study also conﬁrms the results from earlier
retrospective studies that histologically proven acute GI
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scopic abnormalities [9,14] and that a normal endoscopy by
no means excludes aGVHD. It is noteworthy that almost 25%
of the biopsies that were positive for GVHD were taken from
endoscopically normal areas of the intestine.
The principal purpose of the present study was to
compare prospectively sigmoidoscopy and colonoscopy with
respect to their abilities to detect histopathologic ﬁndings
consistent with colonic aGVHD. Consensus is lacking
regarding the gold standard for establishing a diagnosis of
aGVHD. Endoscopic ﬁndings [14] as well as need for treat-
ment with cortisone [12] have been proposed as the most
important elements for securing an accurate diagnosis. In
reality, the eventual diagnosis is usually based on a combi-
nation of assessment of clinical symptoms, endoscopic
ﬁndings, and histopathology. Nevertheless, histopathology is
considered to be the cornerstone of aGVHD diagnostics,
given the low negative predictive value of endoscopic ﬁnd-
ings and the fact that diarrhea is a frequent and nonspeciﬁc
symptom in these patients.
It must be emphasized that a ﬁnding of increased
apoptotic activity per se is not pathognomonic for GVHD but
may also be seen in the early phase after conditioning therapy
or infection [8]. In this context, it is important topoint out that
in the present trial only 2 biopsies were collected within 20
days after the transplant (both on day þ19) and that the
detection of occasional apoptotic bodies was regarded as a
nonspeciﬁcﬁnding and as not consistentwith aGVHD in these
patients. It is even more important to stress that the histo-
pathologic criteria for aGVHD were the same in all cases,
irrespective of the origin of the colonic biopsies. A potential
shortcomingof the studymaybe that biopsieswere evaluated
in a nonblinded matter and having the pathologist who read
the biopsies blinded to their site of origin would have
strengthened the study. However, it should be stressed that
each biopsy sample was evaluated individually using a vali-
dated scale, which does not exclude, but at least minimizes,
the risk of bias related to the evaluation performed by the
pathologist. Because oral sodiumphosphate preparations also
are known to induce apoptosis [15,16], it shouldbementioned
that neither of the2patientswhohadoralNaPpreparation for
their colonoscopies in the present study had any endoscopic
or histopathologic ﬁndings consistent with colonic aGVHD.
The optimal segment of the colon to target for a diag-
nostic biopsy remains a topic of debate. At our center, colo-
noscopy has to date been regarded as a standard procedure
for patients with suspicion of colonic aGVHD. Based on the
results of the present trial, it seems logical to recommend
sigmoidoscopy in the future. However, objections may be
raised to using sigmoidoscopy rather than colonoscopy in
this type of patient because of the risk of missing important
differential diagnoses where histopathologic evidence of
disease in the colon is focal rather than pan-colonic. The
most important alternative diagnosis in this context may be
CMV colitis, because the treatment is speciﬁc and the con-
dition may be severely exacerbated by increased immuno-
suppression. In the present study, the low numbers of
participating patients make it difﬁcult to draw any conclu-
sions as to whether sigmoidoscopy has sufﬁcient sensitivity
for diagnosing CMV colitis, and the results from earlier
retrospective trials are ambiguous in this respect [17,18].
Interestingly, the 2 cases of CMV colitis in the present trial
were not found at all biopsy sites but only from the
ascending colon. Because CMV colitis is relatively rare, it may
not be justiﬁed to subject all patients to colonoscopy solelynot to miss this disease. In situations where CMV colitis is
suspected (eg, colonic aGVHD not responding to treatment,
especially if there is concurrent PCR positivity for CMV in the
blood), a colonoscopy may be considered. In this context, it
should be emphasized that a colonoscopy should always be
performed when the primary differential diagnosis is not
aGVHD (eg, colon cancer). It should also be mentioned that
this study did not include patients with symptoms consistent
with aGVHD primarily of the upper GI tract. Although it is
true that sigmoidoscopy has shown high diagnostic yield
even in this subset of patients [10], gastroduodenoscopy still
may be regarded as the best choice to obtain a diagnosis of
GVHD, at least in the absence of diarrhea.
Additional objections may be raised against the fact that
the 2 different preparations for sigmoidoscopy and colonos-
copy may have an impact on diagnostic yield due to different
cleaning effect of the mucosa. For bowel preparation before
sigmoidoscopy, we normally use enema with bisakodyl 10
mg, twice before the investigation. This regimen is deﬁnitely
much less cumbersome for the patient than the preparation
for colonoscopy. Although the cleaning effect is probably not
quite as high as the preparation for colonoscopy, it is adequate
for assessment of the mucosa. In this matter it may be noted
that the diagnostic yield for the 8 patients fulﬁlling the in-
clusion criterion who underwent sigmoidoscopy during the
studywas almost the sameas for the patientswhounderwent
colonoscopy within the study protocol.
Are rectal biopsies sufﬁcient to obtain a diagnosis of
colonic GVHD? Earlier retrospective trials have claimed that
histopathologic ﬁndings from the rectum show high diag-
nostic yield and a good correlationwith aGVHD at other sites.
However, histopathologic ﬁndings consistent with GVHD
were also found in a high percentage of asymptomatic pa-
tients, which makes the results difﬁcult to interpret [19-22].
The biopsy sample algorithm used in the present trial did not
include rectal biopsies, and, consequently, it is not possible to
comment on its diagnostic yield. However, in a retrospective
study the sensitivity for rectal biopsies was quite low [12]. In
addition, proctoscopy seems to offer no beneﬁt to patients in
terms of preparation, because the protocol is quite similar to
that for sigmoidoscopy.
In summary, sigmoidoscopy is as good as colonoscopy in
establishing a diagnosis of colonic aGVHD in patients who
have diarrhea after allo-SCT. This ﬁnding could have signiﬁ-
cant impact on clinical procedures, because it suggests that
the much less cumbersome sigmoidoscopy procedure is
sufﬁcient to establish an accurate diagnosis for these often
critically ill patients.
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